Crinetics Pharmaceuticals (CRNX)
84.95
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 15-12G Crinetics Pharmaceutical
September 11, 2026 8:40 AM - SEC Filing
Form 8-K Crinetics Pharmaceutical For: Aug 28
August 28, 2026 5:01 PM - SEC Filing
Form 4 Crinetics Pharmaceutical For: Aug 20 Filed by: Schilke Tobin
August 24, 2026 4:53 PM - SEC Filing
Form 8-K Crinetics Pharmaceutical For: Aug 19
August 19, 2026 4:04 PM - SEC Filing
Form 8-K Crinetics Pharmaceutical For: Aug 12
August 14, 2026 8:31 AM - SEC Filing
Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: WELLINGTON MANAGEMENT GROUP LLP
August 13, 2026 4:13 PM - SEC Filing
Form 4 Crinetics Pharmaceutical For: Aug 07 Filed by: Struthers Richard Scott
August 11, 2026 4:12 PM - SEC Filing
H.C. Wainwright Reiterates Neutral Rating on Crinetics (CRNX)
August 11, 2026 6:47 AM - StreetInsider
Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: FMR LLC
August 7, 2026 11:05 AM - SEC Filing
Crinetics Pharmaceuticals (CRNX) Tops Q2 EPS by 8c
August 3, 2026 4:43 PM - StreetInsider
Form 10-Q Crinetics Pharmaceutical For: Jun 30
August 3, 2026 4:13 PM - SEC Filing
Form 8-K Crinetics Pharmaceutical For: Aug 03
August 3, 2026 4:09 PM - SEC Filing
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 3, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
August 3, 2026 8:29 AM - SEC Filing
Form DEFM14A Crinetics Pharmaceutical
July 31, 2026 4:17 PM - SEC Filing
UBS Downgrades Crinetics (CRNX) to Neutral
July 28, 2026 2:38 AM - StreetInsider
Full Article List
